Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000912057-02-020239
Filing Date
2002-05-14
Accepted
2002-05-14 16:09:58
Documents
2
Period of Report
2002-05-03
Items
Item 4: Changes in registrant's certifying accountant
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a2079998z8-ka.htm 8-K/A 10905
3 LETTER OF ARTHUR ANDERSEN a2079998zex-16_1.htm EX-16.1 1419
  Complete submission text file 0000912057-02-020239.txt   14084
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12493 | Film No.: 02646701
SIC: 2836 Biological Products, (No Diagnostic Substances)